↓ Skip to main content

MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies

Overview of attention for article published in Journal of Hematology & Oncology, August 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
2 news outlets
twitter
3 X users

Citations

dimensions_citation
91 Dimensions

Readers on

mendeley
167 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
Published in
Journal of Hematology & Oncology, August 2021
DOI 10.1186/s13045-021-01111-4
Pubmed ID
Authors

Seyed Esmaeil Ahmadi, Samira Rahimi, Bahman Zarandi, Rouzbeh Chegeni, Majid Safa

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 167 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 167 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 23 14%
Student > Bachelor 14 8%
Student > Master 11 7%
Researcher 9 5%
Student > Doctoral Student 6 4%
Other 11 7%
Unknown 93 56%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 35 21%
Medicine and Dentistry 10 6%
Agricultural and Biological Sciences 9 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 2%
Engineering 3 2%
Other 11 7%
Unknown 95 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 February 2023.
All research outputs
#1,754,856
of 23,372,207 outputs
Outputs from Journal of Hematology & Oncology
#116
of 1,211 outputs
Outputs of similar age
#42,665
of 431,745 outputs
Outputs of similar age from Journal of Hematology & Oncology
#7
of 49 outputs
Altmetric has tracked 23,372,207 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,211 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,745 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.